Clinical pharmacology of drugs which influence uric acid production and excretion
- 4 January 1967
- journal article
- review article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 8 (1part1) , 124-138
- https://doi.org/10.1002/cpt196781part1124
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Beneficial Effects of Triacetyl Azauridine in Psoriasis and Mycosis FungoidesAnnals of Internal Medicine, 1966
- Allopurinol in the Treatment of GoutAnnals of Internal Medicine, 1966
- The Effectiveness of the Xanthine Oxidase Inhibitor Allopurinol in the Treatment of GoutAnnals of Internal Medicine, 1965
- STUDIES OF THE URICOGENIC EFFECT OF 2-SUBSTITUTED THIADIAZOLES IN MAN*Journal of Clinical Investigation, 1959
- Results of a clinical trial of g‐28315, a sulfoxide analog of phenylbutazone, as a uricosuric agent in gouty subjectsArthritis & Rheumatism, 1958
- Inhibition of Uric Acid Biosynthesis in Birds by o-Diazoacetyl-l-Serine (Azaserine) and 6-Diazo-5-Oxo-l-Norleucine (DON)American Journal of Physiology-Legacy Content, 1958
- Effect of Pyrazinamide and Pyrazinoic Acid on Urate Clearance and Other Discrete Renal Functions.Experimental Biology and Medicine, 1957
- Paradoxical Retention of Uric Acid by Uricosuric Drugs in Low Dosage.Experimental Biology and Medicine, 1955
- BIOSYNTHESIS OF THE PURINES .2. METABOLISM OF 4-AMINO-5-IMIDAZOLECARBOXAMIDE IN PIGEON LIVER1952
- THE UTILIZATION OF ANTIMETABOLITES IN THE STUDY OF BIOCHEMICAL PROCESSES IN LIVING ORGANISMSAnnals of the New York Academy of Sciences, 1950